Humalog Mix25

Subscribe to Selected New Research on Humalog Mix25

2 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits; contains insulin Lispro & insulin LisproProtamine in a ratio of 25:75%

Bio-Agent Context: Research Results

Hormones, Hormone Substitutes, and Hormone Antagonists

Hormones: 46253

Peptide Hormones: 377

Pancreatic Hormones: 79

Proinsulin: 648

Insulin: 57580

Humalog Mix25: 2

Amino Acids, Peptides, and Proteins

Peptides: 16375

Peptide Hormones: 377

Pancreatic Hormones: 79

Proinsulin: 648

Insulin: 57580

Humalog Mix25: 2

Experts

1.	Herz, M: 1 article (03/2003)
2.	Scholtz, H E: 1 article (03/2003)
3.	Potgieter, M A: 1 article (03/2003)
4.	Campaigne, B N: 1 article (03/2003)
5.	Arora, V: 1 article (03/2003)
6.	Mollentze, W: 1 article (03/2003)

Related Diseases

1.	Type 2 Diabetes Mellitus (MODY) 03/01/2003 - "Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus." 03/01/2003 - "OBJECTIVE: To compare the effects of Humalog Mix25 (Humalog Mix75/25 in the USA) (Mix25) and human insulin 30/70 (30/70) on the 24-hour inpatient plasma glucose (PG) profile in patients with type 2 diabetes mellitus (T2DM). " Order ALL the reference details at left...
2.	Diabetes Mellitus 01/01/2007 - "Insulin lispro, alone (Humalog) or as premixture (Humalog Mix25 or Humalog Mix50) is indicated for the treatment of hyperglycaemia in diabetes mellitus in many countries worldwide. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	insulin LISPRO (Humalog)
2.	Insulin (Novolin)
3.	Glucose (Dextrose)

Best Treatments:
Research Summary Report
on Type 2 Diabetes Mellitus

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 666 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>